European Archives - Page 919 of 1103 - European Medical Journal

Vaccine Developed for Bee Stings

A HIGHLY effective vaccine for European honeybee stings has been developed by researchers from Adelaide, South Australia; the success of this vaccine…

Interleukin-33 Found to Influence Allergy Sensitivity in Neonatal Lungs

A PROTEIN produced by white blood cells, interleukin-33 (IL-33), is a core driver of allergic sensitivity in the lungs of newborns according to the…

Positive Results for Relvar® Ellipta® Lung Function Study in Patients with Well-Controlled Asthma

GlaxoSmithKline plc and Innoviva, Inc. today announced positive headline results from a non-inferiority lung function study

Philips Reinforces Leadership in Image-Guided Therapy Solutions with Global Launch of next Generation Azurion Platform

Amsterdam, the Netherlands, February 22, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA), a leader in health technology, today announced the global launch of…

From EMJ With Love

As February draws to a close, the team here at EMJ are wondering where the time has gone as we busily prepare innovative content for our avid readers!

Are Mitochondria the Key to Cracking Parkinson’s Disease?

THE MITOCHONDRIA of dopamine-producing cells have been linked to Parkinson’s disease, with researchers finding that affected individuals have dopamine…

Glucose Deprivation in the Brain May Correlate with Cognitive Decline

MEMORY, reasoning, and learning are cognitive functions that use up half of all sugar present in the body. Recent research has associated a lack of…

The Evolving Treatment of Clostridium Difficile Infection

Clostridium difficile infection (CDI) rates have been increasing, with a corresponding rise of morbidity and mortality. The primary treatment modality of…

Janssen Presents Newly-Published Data on the Use of ZYTIGA® (Abiraterone Acetate) Plus Prednisone in the Real-World, Outside the Clinical Trial Setting

Beerse, Belgium, February 17, 2017 – Janssen-Cilag International NV today announced the publication of data revealing radiographic progression-free…

New Data Shows Stelara® (Ustekinumab) Maintained Clinical Response and Remission After Two Years of Treatment in Patients with Moderate to Severe Crohn’s Disease

Barcelona, Spain, February 17, 2017 – Janssen-Cilag International NV (“Janssen”) announced today new two-year data from the ongoing IM-UNITI long-term…